Biotech

All Articles

8 months after a $213M fundraise, gene publisher Tome makes decreases

.After raising $213 million in 2023-- among the year's largest private biotech rounds-- Volume Biosc...

BioMarin develops officer crew with biotech veterinarians-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings as...

Biopharma Q2 VC hit highest level considering that '22, while M&ampA decreased

.Equity capital funding into biopharma rose to $9.2 billion across 215 deals in the second fourth of...

Bicara, Zenas look for IPOs to drive late-phase possessions toward market

.Bicara Therapies and also Zenas Biopharma have actually offered fresh incentive to the IPO market a...

Genentech to shut cancer cells immunology analysis team

.Genentech will certainly close its own cancer immunology research study division, and also device h...

Kezar drops strong growth but to confirm its own really worth in phase 1 trial

.Kezar Lifestyle Sciences is falling its own unpromising period 1 solid cyst medicine as the biotech...

Acelyrin loses izokibep, dismisses 3rd of workers

.Even with izokibep maintaining its own newly found winning touch in the medical clinic, Acelyrin is...

Rivus' stage 2 obesity-related cardiac arrest test strikes endpoint

.Rivus Pharmaceuticals has plumped up the potential customers of its fat-busting, muscle-sparing med...

Ovid standstills preclinical job, IV program after soticlestat fail

.Ovid Therapy actually disclosed last month that it was actually trimming back its own headcount as ...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Seaport

.Eli Lilly has actually opened up a $700 million R&ampD facility in the Boston ma Seaport, boosting ...